3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
3
Phase NA
2
Phase 1/2
2
Phase 2
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
13
NET
2
Endocrine
2
CNS
2
Thoracic
1
Sarcoma
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Dermatologic
1
Breast
1
Conditions
Breast Neoplasms
2760
Triple Negative Breast Neoplasms
404
Neoplasm Metastasis
155
Breast Neoplasms, Male
102
Neoplasms
99
Ovarian Neoplasms
68
Carcinoma, Intraductal, Noninfiltrating
68
Carcinoma, Non-Small-Cell Lung
67
Lung Neoplasms
66
Brain Neoplasms
60
Inflammatory Breast Neoplasms
50
Colorectal Neoplasms
49
Breast Carcinoma In Situ
47
Advanced Breast Cancer
47
Prostatic Neoplasms
41
Melanoma
38
Pancreatic Neoplasms
37
Stomach Neoplasms
32
Uterine Cervical Neoplasms
27
Sarcoma
27
HER2-positive Breast Cancer
27
Endometrial Neoplasms
25
Head and Neck Neoplasms
24
Recurrence
23
Colonic Neoplasms
22
Carcinoma, Renal Cell
21
Carcinoma, Ovarian Epithelial
21
Multiple Myeloma
20
Carcinoma, Ductal, Breast
20
Small Cell Lung Carcinoma
19
Interventions
alectinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Intestinal Neoplasms
×
Breast
×
Clear all
NCT04644315
2023-08-07
ALpha-T
Hoffmann-La Roche
Phase 2
Terminated
1 enrolled
5 charts